The AI in Business Podcast

The growing use of AI‑driven modeling in clinical development is exposing how limited traditional, single‑study dose selection and patient assessment methods have been for complex oncology programs. In this episode, Shefali Kakar, Global Head of PK Sciences and Oncology at Novartis, examines how deeper data integration across phases enables more precise dose decisions, clearer safety interpretation, and a more consistent understanding of patient variability alongside host Matthew DeMello. She outlines how longitudinal analysis, exposure–response modeling, and covariate evaluation are helping teams reduce unnecessary sub‑studies, tailor dosing for diverse patient groups, and strengthen cross‑functional decision‑making throughout development.  According to Nielsen, 91% of podcast listening happens alone, creating a focused, distraction-light environment well suited for complex B2B messaging.


Learn how leading brands and AI startups connect with enterprise AI buyer audiences at scale by downloading our media kit at go.emerj.com/partner

The pressure on financial services AI leaders to show board-level results has intensified — yet the pace of vendor pitches, shifting tooling stacks, and stalled pilots has made action feel riskier than waiting. In this episode, Art Shectman, CEO and Founder at Elephant Ventures, breaks down why the instinct to evaluate everything before building anything is the primary obstacle to production, and what a realistic first step actually looks like inside a regulated enterprise. The conversation covers how to identify the right initial workflow, how to structure a time-boxed sprint toward a minimum viable production deployment, and how to present early AI wins to boards that have stopped trusting strategy decks.


This episode is sponsored by Elephant Ventures. Learn how brands work with Emerj and other Emerj Media options at go.emerj.com/partner

The reason enterprise AI programmes stall is not the technology — it is the sequence in which decisions are made before and after the pilot succeeds. In this episode, Ronny Fehling, Chief AI Transformation Officer at HTEC, examines why AI initiatives lose momentum at the production threshold and what organisational conditions determine whether they make it through. The discussion covers production slices, decision gates with kill-switch authority, use case discipline, and why top-down AI mandates tend to reproduce the same failure modes regardless of budget.
This episode is sponsored by HTEC.


Learn how brands work with Emerj and other Emerj Media options at go.emerj.com/partner

Deepfake voice fraud is not bypassing enterprise security technology, it is beating the workflows agents rely on to make trust decisions in real time. In this episode, Jon-Rav Shende, Global CTO for Data and AI at Thales Group, outlines where enterprise voice channels are most exposed, why identity, urgency, and business action converging in a single call represents the highest risk point, and what a practical four-step response framework looks like for regulated organisations. The discussion covers how to map risky voice journeys, define escalation decision points, build the evidence chains auditors and cyber insurers will require, and deploy AI as a risk signal layer without automating high-risk actions beyond appropriate controls.
​
This episode is sponsored by Modulate. Learn how brands work with Emerj and other Emerj Media options at go.emerj.com/partner

A growing share of pharmaceutical innovation is now constrained not by scientific imagination, but by the infrastructure required to support AI at scale. In this episode of the AI in Business podcast, Thomas Fuchs, Chief AI Officer at Eli Lilly & Company, joins Matthew DeMello to explore how Lilly's new AI supercomputing platform is reshaping scientific discovery and enterprise operations. The conversation examines how large-scale computing enables more advanced models, secure and usable data environments, and faster scientific iteration across the organization. Learn how brands work with Emerj and other Emerj Media options at go.emerj.com/partner